Equistone’s Concept Life Sciences bolts on Agenda1

The GP said Agenda1 will grow through its connection to the Concept Life Sciences group, but the company will also expand its range of services. Agenda1's founders will continue to manage the company.

It marks the second bolt-on for Concept Life Sciences, which was formed in 2014 through a merger of three Equistone portfolio companies, Peakdale Molecular, Resource & Environment Consultants and Scientific Analysis Laboratories.

The first bolt-on for Concept Life Sciences was CXR Biosciences in August 2015. The company supports life sciences companies in resolving issues around the safety of compounds.

Company
Established in 2006 and based in Bradford, Agenda1 is a specialist contract analytical company, delivering support services to pharmaceutical, healthcare and medical device companies.

People
Andi Tomkinson is investment director at Equistone. Michael Fort is executive chairman at Concept Life Sciences.

Advisers
Acquirer – Addleshaw Goddard (Legal); PwC (Tax); Deloitte (Tax); CIL (Commercial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Portfolio management
• United Kingdom